Oliver's campaign

Oliver's story 

Eight-year-old Oliver loves Lego, Disney films and superheroes like The Flash! 

Just before his third birthday, Oliver began acting a little less like himself. After being referred to their local hospital, on his third birthday, a large tumour was found in his chest, and he was diagnosed with high-risk neuroblastoma. During his treatment, baby sister, Eva, was also diagnosed with intermediate-risk neuroblastoma. 

Oliver completed frontline treatment in late 2018 and his end of treatment scans showed he was clear of disease. In February 2019, Oliver and his family travelled to New York so he could start the bivalent vaccine clinical trial, which he completed in February 2020. 

Sadly, in the summer of 2022, Oliver’s disease returned, and he has since been receiving treatment for this on the NHS. Once Oliver is back in remission, the family aim for him to access further maintenance therapy.  

Oliver’s campaign remains open in case he needs any potentially life-saving treatment in the future not available through the NHS, which could cost hundreds of thousands of pounds. 

Treatment so far 

After his diagnosis he began eight rounds of chemotherapy – this worked and got rid of most of the cancer. He then had major surgery to remove the remaining primary tumour, which was followed by high-dose chemotherapy and a stem cell transplant.  

Oliver then received immunotherapy and 14 rounds of radiotherapy to complete his frontline treatment in November 2018. Whilst Oliver was undergoing treatment, in October 2017, his little sister, Eva, was diagnosed with intermediate-risk neuroblastoma. She received chemotherapy and had two surgeries. 

Oliver’s end of treatment scans showed he was clear of disease, so in February 2019, Oliver and his family travelled to New York so he could start the bivalent vaccine clinical trial. He completed the trial in February 2020. 

_{Solving Kids' Cancer UK's children's fundraising campaigns} 

_{Funds raised will go towards helping Oliver and his family. If Oliver no longer needs the funds or is in remission five years post the end of successful treatment, the funds will be used to support other children and families affected by neuroblastoma through our activities. For children with high-risk neuroblastoma, like Oliver, the survival rate is much lower than other childhood cancers. Upon relapse, this rate reduces even further.}